Adaptive mechanisms of Campylobacter jejunito erythromycin treatment
Open Access
- 14 June 2013
- journal article
- research article
- Published by Springer Nature in BMC Microbiology
- Vol. 13 (1) , 1-16
Abstract
Macrolide is the drug of choice to treat human campylobacteriosis, but Campylobacter resistance to this antibiotic is rising. The mechanisms employed by Campylobacter jejuni to adapt to erythromycin treatment remain unknown and are examined in this study. The transcriptomic response of C. jejuni NCTC 11168 to erythromycin (Ery) treatment was determined by competitive microarray hybridizations. Representative genes identified to be differentially expressed were further characterized by constructing mutants and assessing their involvement in antimicrobial susceptibility, oxidative stress tolerance, and chicken colonization. Following the treatment with an inhibitory dose of Ery, 139 genes were up-regulated and 119 were down-regulated. Many genes associated with flagellar biosynthesis and motility was up-regulated, while many genes involved in tricarboxylic acid cycle, electron transport, and ribonucleotide biosynthesis were down-regulated. Exposure to a sub-inhibitory dose of Ery resulted in differential expression of much fewer genes. Interestingly, two putative drug efflux operons (cj0309c-cj0310c and cj1173-cj1174) were up-regulated. Although mutation of the two operons did not alter the susceptibility of C. jejuni to antimicrobials, it reduced Campylobacter growth under high-level oxygen. Another notable finding is the consistent up-regulation of cj1169c-cj1170c, of which cj1170c encodes a known phosphokinase, an important regulatory protein in C. jejuni. Mutation of the cj1169c-cj1170c rendered C. jejuni less tolerant to atmospheric oxygen and reduced Campylobacter colonization and transmission in chickens. These findings indicate that Ery treatment elicits a range of changes in C. jejuni transcriptome and affects the expression of genes important for in vitro and in vivo adaptation. Up-regulation of motility and down-regulation of energy metabolism likely facilitate Campylobacter to survive during Ery treatment. These findings provide new insight into Campylobacter adaptive response to antibiotic treatment and may help to understand the mechanisms underlying antibiotic resistance development.Keywords
This publication has 43 references indexed in Scilit:
- Impaired Fitness and Transmission of Macrolide-Resistant Campylobacter jejuni in Its Natural HostAntimicrobial Agents and Chemotherapy, 2012
- Global Analysis of the Staphylococcus aureus Response to MupirocinAntimicrobial Agents and Chemotherapy, 2012
- Influence of Season and Geography on Campylobacter jejuni and C. coli Subtypes in Housed Broiler Flocks Reared in Great BritainApplied and Environmental Microbiology, 2011
- Phenotypic and Genotypic Evidence for l -Fucose Utilization by Campylobacter jejuniJournal of Bacteriology, 2011
- Contribution of the Multidrug Efflux Transporter CmeABC to Antibiotic Resistance in Different Campylobacter SpeciesFoodborne Pathogens and Disease, 2010
- A coordinated network of transporters with overlapping specificities provides a robust survival strategyProceedings of the National Academy of Sciences, 2009
- Structure of a σ28-Regulated Nonflagellar Virulence Protein from Campylobacter jejuniJournal of Molecular Biology, 2008
- CmeR Functions as a Pleiotropic Regulator and Is Required for Optimal Colonization of Campylobacter jejuni In VivoJournal of Bacteriology, 2008
- Identification of a Spermidine Excretion Protein Complex (MdtJI) in Escherichia coliJournal of Bacteriology, 2008
- Effect of Macrolide Usage on Emergence of Erythromycin-Resistant Campylobacter Isolates in ChickensAntimicrobial Agents and Chemotherapy, 2007